Light and Oxygen for the Cellular Drug Delivery and Tracking
A special issue of Pharmaceutics (ISSN 1999-4923). This special issue belongs to the section "Drug Delivery and Controlled Release".
Deadline for manuscript submissions: closed (30 April 2021) | Viewed by 4784
Special Issue Editors
Interests: drug delivery; breast cancer treatment; magnetic resonance imaging; magnetic resonance spectroscopy; drug tracking; drug monitoring; molecular imaging
Special Issues, Collections and Topics in MDPI journals
Interests: photochemistry; photobiology; medical chemistry
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
This Special Issue will be dedicated to Photodynamic therapy (PDT) which uses dyes, light and oxygen to destroy tumors. PDT is an emerging treatment method for cancer and other diseases that uses photo-generated reactive oxygen species (ROS) to damage targeted cancer cells or to inactivate bacteria. For generation of ROS, a PDT treatment method employs photosensitizers (PS) that are excited by external illumination provided by visible light at power levels that do not damage healthy tissue. The primary ROS generated is singlet oxygen (1O2) which reacts with cell molecules ultimately resulting in tissue damage and cell death. The mechanism of singlet oxygen formation in this system is energy transfer from excited PS to ground state oxygen. Other ROS such as superoxide and hydroxyl radical are also generated to a much lesser extent and can be also toxic to cells. This Special Issue of Light and Oxygen for Cellular Drug Delivery and Tracking will cover all aspects of this field and welcomes both original research and comprehensive review papers, case reports to guide a wide readership toward the most recent and ground-breaking research.
Dr. Dorota Bartusik-Aebisher
Dr. David Aebisher
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmaceutics is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- photodynamic therapy
- photosynthetizers
- light
- oxygen
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.